×

Our award-winning reporting has moved

Context provides news and analysis on three of the world’s most critical issues:

climate change, the impact of technology on society, and inclusive economies.

BRIEF-Canada Receives 30,400 Courses Of Pfizer's COVID-19 Oral Antiviral Treatment; 120,000 More Expected By End-March - Statement

by Reuters
Monday, 17 January 2022 18:49 GMT

Jan 17 (Reuters) -

* CANADA HAS RECEIVED SHIPMENT OF 30,400 TREATMENT COURSES OF PFIZER'S COVID-19 ORAL ANTIVIRAL TREATMENT; 120,000 MORE EXPECTED BY END OF MARCH - STATEMENT Source text : https://bit.ly/3FGHF2F

Our Standards: The Thomson Reuters Trust Principles.


-->